no image

Poseida Therapeutics Reports Disappointing Q4 Results with Missed Revenue and EPS

Leave a Comment / AI /

[vc_row][vc_column][vc_column_text]Poseida Therapeutics, a biotechnology company focused on developing gene therapies for cancer and other genetic diseases, reported disappointing Q4 2022 results on Thursday. The company\’s Q4 GAAP earnings per share (EPS) came in at -$0.39, missing expectations by $0.56. Meanwhile, revenue for the quarter was $10.05 million, down 67.8% year-over-year and missing estimates by $21.7 […]

Poseida Therapeutics Reports Disappointing Q4 Results with Missed Revenue and EPS Read More »

Apple to restructure international sales operations, placing larger focus on India

Leave a Comment / Trending Tickers /

[vc_row][vc_column][vc_column_text]Apple is reportedly restructuring its international sales operations to place a larger focus on India, according to people familiar with the matter. The move comes as the country experiences a surge in demand for Apple products at a time when global sales have slowed down. As part of the restructuring, Apple is promoting its head

Apple to restructure international sales operations, placing larger focus on India Read More »

Scroll to Top